William Blair started covering Concentra Group Holdings Parent Inc. (CON) on Wednesday with an Outperform rating, and the message is pretty clear: this company knows what it's doing.

Concentra is a U.S. healthcare company that focuses on occupational medicine, urgent care, and physical therapy. Think of it as the go-to for workplace injuries and employer health needs.

Why the Analyst Likes It

Analyst Jared Haase wrote that Concentra is "both producing strong operational and financial results and helping employers manage the lifeblood of their business—the workforce." He acknowledges the stock trades at a premium — roughly 10.5 times his 2027 adjusted EBITDA estimate versus the peer group average of 10 times — but says that premium is warranted. "We believe a modest premium is warranted given the company's unique operating model and compelling growth outlook," Haase noted.

William Blair also points out that Concentra is the market leader in occupational medicine, which is a large and attractive market. That leadership position gives it a competitive edge.

Strong Quarter, Higher Guidance

Concentra reported first-quarter adjusted earnings of 40 cents per share, beating the consensus estimate of 35 cents. Revenue jumped 13.7% to $569.56 million, also topping expectations of $553.49 million.

The company raised its fiscal 2026 sales guidance to a range of $2.27 billion to $2.375 billion, up from the prior $2.25 billion to $2.35 billion. The new midpoint is above the consensus of $2.312 billion.

The Bigger Picture: Workplace Injuries Are Expensive

According to the National Safety Council, workplace injuries cost a staggering $181 billion in 2024. That includes $37 billion in direct medical expenses and $145 billion in indirect costs like lost productivity, administrative and legal expenses, and uninsured employee costs. Indirect costs alone made up nearly 80% of the total.

Concentra's model focuses on delivering quality care while shortening claims duration, which helps employers reduce those indirect costs. The analyst also noted that employment levels and workplace injury rates support long-term growth in this market.

Stock Action

Shares of Concentra were up 3.26% at $30.72 on Wednesday, hitting a new 52-week high. The market seems to agree with William Blair's take.